Skip to main content

Conestat alfa Disease Interactions

There is 1 disease interaction with conestat alfa.

Moderate

Conestat alfa (applies to conestat alfa) thromboembolism

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: History - Thrombotic/Thromboembolic Disorder, Thrombotic/Thromboembolic Disorder

Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of plasma derived conestat alfa. Patients with risk factors such as, prior history of thrombosis might be at an increased risk. It is recommended to monitor patients with known risk factors for TE events during and after therapy administration.

References

  1. (2015) "Product Information. Ruconest (conestat alfa)." Valeant Pharmaceuticals

Conestat alfa drug interactions

There are 48 drug interactions with conestat alfa.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer